Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
Crossref DOI link: https://doi.org/10.1007/s10549-016-3828-6
Published Online: 2016-05-11
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jacot, William
Pons, Elvire
Frenel, Jean-Sébastien
Guiu, Séverine
Levy, Christelle
Heudel, Pierre Etienne
Bachelot, Thomas
D’Hondt, Véronique
Darlix, Amélie
Firmin, Nelly
Romieu, Gilles
Thezenas, Simon
Dalenc, Florence
Text and Data Mining valid from 2016-05-11